Clearmind Medicine Inc.

CMND

$0.24

$-0.14 (-37.83%)

Closed

Clearmind Medicine sets 1-for-10 reverse stock split effective May 21, 2026

Loading chart...

IndexN/A

Market Cap0.00B

Enterprise Value0.00B

Income$-0.01B

Sales$0.00B

EmployeesN/A

P/E-0.01

P/SN/A

P/B3.39

P/C-0.85

EV/EBITDA-0.51

EV/SalesN/A

EPS (ttm)-24.12

EarningsN/A

Gross Margin0.00%

Oper. Margin0.00%

Profit Margin0.00%

Volume5.03M

Shs Outstand0.00B

Change-37.83%

Dividend Est.N/A

Dividend Ex-DateN/A

Perf YTDN/A

Perf YearN/A

Perf 3YN/A

Perf 5YN/A

Perf 10YN/A

IPON/A

Yesterday06:00AMClearmind Medicine Announces 1-for-10 Reverse Share Split(globenewswire.com)06:00AMClearmind Medicine Announces 1-for-10 Reverse Share Split(globenewswire.com)

May 1808:42AMClearmind Medicine Signs Agreement to Examine MEAI in Combination and Sequencing with Tirzepatide Against Blockbuster GLP-1 Medications(globenewswire.com)08:42AMClearmind Medicine Signs Agreement to Examine MEAI in Combination and Sequencing with Tirzepatide Against Blockbuster GLP-1 Medications

Insider Trading

No insider trades found for CMND.

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

CEO: Adi Zuloff-ShaniEmployees: 4www.clearmindmedicine.com

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	$69.19K	$71.09K	$79.06K	$119.62K	$2.53K	N/A	N/A	N/A
Gross Profit	$-69.19K	$-71.09K	$-79.06K	$-119.62K	$-2.53K	N/A	N/A	N/A
Gross Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses	$7.87M	$7.93M	$8.59M	$8.88M	$3.61M	$230.12K	$104.15K	$259.19K
Operating Income	$-7.94M	$-8.00M	$-8.67M	$-9.00M	$-3.61M	$-230.12K	$-104.15K	$-259.19K
Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income	$-5.41M	$-7.31M	$-11.85M	$-9.93M	$-3.66M	$-230.12K	$-104.15K	$-198.09K
Net Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS (Basic)	$-42.53	$-94.38	$-2341.32	$-9164.43	$-4731.05	$-507.60	$-337.61	$-735.01
EBITDA	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Stock Option Compensation Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Price To Earnings Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Price To Sales Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Market Capitalization	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Clearmind Medicine Inc.

Insider Trading

Discover more